1999
DOI: 10.1176/ajp.156.6.885
|View full text |Cite
|
Sign up to set email alerts
|

Persistence of Haloperidol in Human Brain Tissue

Abstract: Objective: After discontinuation of neuroleptic drugs, their antipsychotic and antiparkinsonian effects are still present for a prolonged period. It is not known whether the extended effects of neuroleptic drugs in humans are due to the continued presence of drug in brain tissue or to long-lasting drug-induced physiologic changes. The aim of this study was to directly examine haloperidol concentrations in human brain tissue in relation to drug-free time. Method: Haloperidol concentrations were measured in five… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
55
0
1

Year Published

2004
2004
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 132 publications
(58 citation statements)
references
References 35 publications
2
55
0
1
Order By: Relevance
“…Consequently, the final concentration of drug in the animals is likely to be much lower than the concentrations present on the NGM plates. Nonetheless, all three of these drugs inhibited nuclear localization of DAF-16::GFP at concentrations equivalent to those required to antagonize dopamine receptors in C. elegans under identical conditions (36) and similar to those reached with accumulation in tissues including the human brain (37,38). Thus, stimulation of Akt signaling and antagonism of dopamine receptors occur in the same concentration range in this species.…”
Section: Resultsmentioning
confidence: 55%
“…Consequently, the final concentration of drug in the animals is likely to be much lower than the concentrations present on the NGM plates. Nonetheless, all three of these drugs inhibited nuclear localization of DAF-16::GFP at concentrations equivalent to those required to antagonize dopamine receptors in C. elegans under identical conditions (36) and similar to those reached with accumulation in tissues including the human brain (37,38). Thus, stimulation of Akt signaling and antagonism of dopamine receptors occur in the same concentration range in this species.…”
Section: Resultsmentioning
confidence: 55%
“…Furthermore, haloperidol concentrations in the range between 8.9 and 226 mM have been shown in human post-mortem brain tissue. 49 In conclusion, various types of neuroleptics at therapeutic concentrations act as noncompetitive antagonists at the 5-HT 3 receptor. This effect, therefore, may contribute to the antipsychotic efficacy of such compounds and may constitute a not yet recognized pharmacological principle of neuroleptics.…”
Section: Discussionmentioning
confidence: 95%
“…This scenario may well reflect our human data, as antipsychotic drugs were detectable in only two patients at the time of autopsy. Given a 6.8-week half-life of haloperidol in the human brain (Kornhuber et al, 1999), it seems that many patients were not taking medications for a number of weeks before death. The effects of clozapine seemed to be limited to increasing VAMP levels; SNAP-25 was unchanged.…”
Section: Antipsychotic Drug Effectsmentioning
confidence: 99%